AIMZ Investment Advisors LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 0.8% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 5,578 shares of the healthcare conglomerate’s stock after acquiring an additional 47 shares during the quarter. AIMZ Investment Advisors LLC’s holdings in UnitedHealth Group were worth $2,922,000 at the end of the most recent reporting period.
A number of other large investors also recently added to or reduced their stakes in UNH. Brighton Jones LLC boosted its holdings in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after acquiring an additional 28,231 shares during the period. Revolve Wealth Partners LLC boosted its stake in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares during the period. Capital Analysts LLC increased its stake in UnitedHealth Group by 1.0% during the 4th quarter. Capital Analysts LLC now owns 11,046 shares of the healthcare conglomerate’s stock worth $5,587,000 after buying an additional 111 shares during the period. Coldstream Capital Management Inc. boosted its position in UnitedHealth Group by 2.5% in the 4th quarter. Coldstream Capital Management Inc. now owns 27,382 shares of the healthcare conglomerate’s stock valued at $13,852,000 after buying an additional 660 shares during the period. Finally, Boothbay Fund Management LLC increased its position in shares of UnitedHealth Group by 117.2% during the fourth quarter. Boothbay Fund Management LLC now owns 9,129 shares of the healthcare conglomerate’s stock worth $4,618,000 after acquiring an additional 4,925 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. This represents a 5.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.28% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
View Our Latest Research Report on UnitedHealth Group
UnitedHealth Group Price Performance
Shares of NYSE:UNH opened at $307.0980 on Friday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The firm has a market capitalization of $278.13 billion, a P/E ratio of 13.31, a P/E/G ratio of 1.98 and a beta of 0.43. The company’s fifty day moving average price is $288.39 and its 200 day moving average price is $388.53.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same period in the previous year, the business posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- Top Stocks Investing in 5G Technology
- Equal Weight ETFs: Hidden Upside in Today’s Market
- How to Calculate Options Profits
- Zillow Group Approaching Key Technical Levels: Is It Time to Buy?
- What is a Death Cross in Stocks?
- For True Diversification: 3 Stocks You Can Buy Now
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.